17-hydroxy-19-nor-21-carboxylic acidsteroid gamma-lactone derivative, use thereof, and medicament containing the derivative

Details for Australian Patent Application No. 2008342910 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Bohlmann, Rolf; Muhn, Hans Peter; Kuhnke, Joachim; Prelle, Katja; Ring, Sven; Klar, Ulrich; Menges, Frederik; Hubner, Jan; Frenzel, Thomas; Borden, Steffen

Agent Davies Collison Cave

Pub. Number AU-A-2008342910

PCT Pub. Number WO2009/083266

Priority 10 2007 063 503.8 29.12.07 DE

Filing date 23 December 2008

Wipo publication date 9 July 2009

International Classifications

C07J 53/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms

A61K 31/585 (2006.01)

A61P 5/34 (2006.01) Drugs for disorders of the endocrine system

Event Publications

15 July 2010 PCT application entered the National Phase

  PCT publication WO2009/083266 Priority application(s): WO2009/083266

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008342912-17-(1'-propenyl)-17-3'-oxidoestra-4-en3-one derivative, use thereof, and medicament containing said derivative

2008342802-Packaging for tobacco industry products